secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2023-03-07T23:59:59+00:00
Accession:  0001493152-23-006880
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical Q4 revenue up 9% to $15.3M; full year net loss widens to $8.5M
----------------------------------------------------------------------------

- Q4 revenue $15.3M, up 9% YoY; full year revenue $58.0M, up 5% YoY.
- Q4 net loss $2.2M ($0.02 per share), vs $2.3M ($0.03) in prior year.
- Full year net loss $8.5M ($0.09 per share), up from $4.8M ($0.06) in 2021.
- Non-GAAP Adjusted EBITDA full year loss $3.0M vs gain $0.3M in 2021.
- Acquired Coflex product line to enhance fixation offering; financial details not disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223006880/0001493152-23-006880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223006880/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-006880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer